$129.96 Billion Non-Oncology Precision Medicine Market, 2019-2020 & 2030 – Research Alliance Across Industry and Academia Accelerating Market…

Posted: November 4, 2020 at 11:56 am

DUBLIN, Nov. 4, 2020 /PRNewswire/ -- The "Global Non-Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 Countries) - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

The global non-oncology precision medicine market was valued at $41.1 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.03% and reach a value of $129.96 billion in 2030.

The precision medicine approach is used for several disease management, such as oncology, immunology, neurology, and infectious diseases. In the non-oncology precision medicine market, the application of molecular biology is for studying the cause of a patient's disease at the molecular level for diseases other than cancer, so that target-based therapies or individualized therapies can be applied to cure the patient's health-related problems.

The existing non-oncology precision medicine market is favored by multiple factors, which include rising government initiatives, coupled up with the general population's growing awareness pertaining to molecular level diagnosis and treatment. Additionally, the increasing number of advancements in molecular diagnostics, more key players interested in investing for the development of novel personalized therapies, and increasing FDA approvals for such drugs among others.

Competitive Landscape

The non-oncology precision medicine market witnessed 59 collaborations and partnerships, four fundings and investments, 44 product launches and enhancements,26 regulatory and legal activities,18 mergers and acquisitions, and six business expansions during the period January 2016-August 2020.

Key Topics Covered:

1 Product Definition

2 Scope of the Research Study

3 Research Methodology3.1 Primary Data Sources3.2 Secondary Data Sources3.3 Market Estimation Model3.4 Selection Criteria for Company Profiles

4 Market Overview4.1 Introduction4.2 Enabling Technologies of Precision Medicine Emphasizing Focus on Prevention4.3 Promising Potential and Role of Precision Medicine

5 Impact of COVID-19 Pandemic on Global Non-Oncology Precision Medicine Market5.1 Unprecedented Demand for Non-Oncology Precision Medicine Due to COVID-195.2 COVID-19 Affecting Supply Chain of Non-Oncology Precision Medicine-Based Therapies5.3 Measures Taken to Address Current Problem

6 Global Non-Oncology Precision Medicine Market: Industry Analysis6.1 Legal and Regulatory Framework and Requirements6.1.1 North America6.1.1.1 Regulatory Requirements in U.S.6.1.2 Europe6.1.3 Asia-Pacific6.2 Patent Landscape

7 Global Non-Oncology Precision Medicine Market: Market Dynamics7.1 Overview7.2 Market Driving Factors7.2.1 Improved Availability of Targeted Therapies and Decreasing Trial and Error-Based Prescription7.2.2 Reduced Chances of Adverse Drug Reactions7.2.3 Decreasing Overall Cost of Genome Sequencing7.2.4 Rising Prevalence of Chronic Diseases7.3 Market Restraining Factors7.3.1 Unclear Regulatory Framework and Reimbursement Scenario for Personalized Medicine7.3.2 Limited Knowledge About Molecular Mechanism/Interaction7.3.3 Integrating and Securing Electronic Health Records7.4 Market Opportunities7.4.1 Research Alliance Across Industry and Academia Accelerating Market Entry7.4.2 Strong Pipeline and Increasing FDA Approvals

8 Global Non-Oncology Precision Medicine Market: Competitive Landscape8.1 Key Strategies and Developments8.1.1 Product Offerings8.1.2 Partnerships and Alliances8.1.3 Regulatory and Legal8.1.4 Mergers and Acquisitions8.1.5 Funding and Investments8.2 Market Share Analysis8.3 Growth-Share Analysis (by Company), 2019

9 Global Non-Oncology Precision Medicine Market (by Application), $Billion, 2019-20309.1 Overview9.2 Infectious Diseases9.2.1 Respiratory Infections9.2.2 Gastrointestinal Infections9.2.3 Sexually Transmitted Infections9.2.4 Others9.3 Neurology/Physiatry9.3.1 Neurodegenerative Disorders9.3.2 Neuropsychiatric Disorders9.3.3 Others9.4 Lifestyle and Endocrinology9.5 Cardiovascular9.5.1 Cardiac Myopathies and Arrhythmia9.5.2 Others9.6 Gastroenterology9.7 Other Applications

10 Global Non-Oncology Precision Medicine Market (by Ecosystem), $Billion, 2019-203010.1 Overview10.2 Applied Sciences10.2.1 Genomics10.2.2 Global Non-Oncology Precision Medicine Genomics Market (by Technology) Polymerase Chain Reaction (PCR) Precision Medicine Next-Generation Sequencing (PM NGS) Genome Editing10.2.2.4 Other Technologies10.2.3 Pharmacogenomics10.2.4 Other Applied Sciences10.3 Precision Diagnostics10.3.1 Molecular Diagnostics (MDx)10.3.2 Medical Imaging10.4 Digital Health and Information Technology10.4.1 Clinical Decision Support Systems (CDSS)10.4.2 Big Data Analytics10.4.3 IT Infrastructure10.4.4 Genomics Informatics10.4.5 In-Silico Informatics10.4.6 Mobile Health10.5 Precision Therapeutics10.5.1 Clinical Trials10.5.2 Cell Therapy10.5.3 Drug Discovery and Research10.5.4 Gene Therapy

11 Global Non-Oncology Precision Medicine Market (by Region), $Billion, 2019-2030

12 Company Profiles12.1 Company Overview12.2 Role of Abbott Laboratories in Global Non-Oncology Precision Medicine Market12.3 Financials12.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/j2b11m

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


View original post here:
$129.96 Billion Non-Oncology Precision Medicine Market, 2019-2020 & 2030 - Research Alliance Across Industry and Academia Accelerating Market...

Related Post

Comments are closed.